{
    "eid": "2-s2.0-85164863670",
    "title": "Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation",
    "cover-date": "2023-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Lalida Tantisuwat",
        "Nakkawee Saengklub",
        "Pakit Boonpala",
        "Sarawut Kumphune",
        "Yaowalak Panyasing",
        "Sarinee Kalandakanond-Thongsong",
        "Anusak Kijtawornrat"
    ],
    "citedby-count": 1,
    "ref-count": 60,
    "ref-list": [
        "2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",
        "Review of diagnostic and therapeutic approach to canine myxomatous mitral valve disease",
        "Clinical pharmacokinetics of sacubitril/valsartan (LCZ696): A novel angiotensin receptor-neprilysin inhibitor",
        "Clinical practice. Systolic heart failure",
        "Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group",
        "Global public health burden of heart failure",
        "Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure",
        "The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy",
        "Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling",
        "New biomarkers for primary mitral regurgitation",
        "Autophagy as a mechanism for myolysis of cardiomyocytes in mitral regurgitation",
        "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC",
        "Effect of neprilysin inhibition on various natriuretic peptide assays",
        "Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure",
        "LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice",
        "Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients",
        "LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy",
        "Angiotensin-neprilysin inhibition versus enalapril in heart failure",
        "Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation",
        "The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet",
        "Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts",
        "Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: Benefits of ventricular remodeling and exercise capacity",
        "Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation",
        "Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure",
        "Short-term effects of sacubitril/valsartan on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease",
        "Sacubitril/valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits",
        "Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction",
        "Mitral valve regurgitation in the contemporary era: Insights into diagnosis, management, and future directions",
        "Sacubitril/valsartan improves left atrial and left atrial appendage function in patients with atrial fibrillation and in pressure overload-induced mice",
        "AHU377+valsartan (LCZ696) modulates renin-angiotensin system (RAS) in the cardiac of female spontaneously hypertensive rats compared with valsartan",
        "Ultrastructural adaptation of the cardiomyocyte to chronic mitral regurgitation",
        "Sacubitril/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts",
        "LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis",
        "Renin-angiotensin blockade combined with natriuretic peptide system augmentation: Novel therapeutic concepts to combat heart failure",
        "Sacubitril/valsartan as antifibrotic drug: Rejuvenating the fibrosed HFpEF heart",
        "Mitochondrial DNA, mitochondrial dysfunction, and cardiac manifestations",
        "Mitochondrial dysfunction in pathophysiology of heart failure",
        "Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%",
        "Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart",
        "PINK1 is selectively stabilized on impaired mitochondria to activate Parkin",
        "Xin Fu Kang oral liquid inhibits excessive myocardial mitophagy in a rat model of advanced heart failure",
        "Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure",
        "Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation",
        "The role of natriuretic peptides in cardioprotection",
        "Mas receptor mediates cardioprotection of angiotensin-(1\u20137) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress",
        "Angiotensin II and oxidative stress in the failing heart",
        "Effect of autophagy on myocardial infarction and its mechanism",
        ".). Committee for the Update of the Guide for the Care and Use of Laboratory Animals",
        "An image guided transapical mitral valve leaflet puncture model of controlled volume overload from mitral regurgitation in the rat",
        "Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging",
        "Echocardiographic evaluation of cardiac function in ischemic rats: Value of m-mode echocardiography",
        "Sacubitril/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR-181a in a rodent chronic myocardial infarction model",
        "Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria",
        "Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury",
        "The role and study of mitochondrial impairment and oxidative stress in cholestasis",
        "15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors",
        "LC3B, a protein that serves as an autophagic marker, modulates angiotensin II-induced myocardial hypertrophy",
        "Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats",
        "Mitochondrial dynamics modulation as a critical contribution for Shenmai injection in attenuating hypoxia/reoxygenation injury",
        "Analyzing real-time PCR data by the comparative C(T) method"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University Laboratory Animal Center",
        "Chulalongkorn University"
    ]
}